Cost-effectiveness analysis: discount the placebo at your peril.

Medical decision making : an international journal of the Society for Medical Decision Making

Volumn 30, Issue 5, 2010, Pages 536-543

  Hawkins, Neil ^a   Scott, David A ^b  

^a ICON PLC   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; ECONOMICS; EPILEPSY; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PLACEBO EFFECT; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; EPILEPSY; HUMANS; MODELS, ECONOMIC; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE; PLACEBO EFFECT; QUALITY-ADJUSTED LIFE YEARS;

EID: 79952279807     PISSN: None     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10362106     Document Type: Article

References (0)